Home

Phillip G. Febbo

CIK 1649245 · Chief Scientific & Med Officer · last filed 2026-09-04

Phillip G. Febbo is a Chief Scientific & Med Officer who has filed 53 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for VCYT, was dated Sep 4, 2026. Across all open-market trades the lifetime net is −$4.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.2M across reported positions. 18 SEC filings were submitted jointly with ILLUMINA, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.17M

Companies

4

Total Filings

53

Lifetime Open-Market Net

-$4.22M

Filer Profile

Reported Address
C/O VERACYTE, INC.
6000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO, CA 94080
Related Filers
ILLUMINA, INC. — 18 joint filings, latest 2023-03-03
VARIAN MEDICAL SYSTEMS INC — 5 joint filings, latest 2021-04-16
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VCYT Chief Scientific & Med Officer 135,753 $41.52 $5.64M -$1.79M 16 2026-09-04
ILMN SVP Chief Medical Officer 14,786 $238.82 $3.53M -$1.72M 17 2023-03-03
VARIAN MEDICAL SYSTEMS INC (VAR) Delisted Director 9 $177.07 $1.6K $0 4 2021-04-16
GENOMIC HEALTH INC (GHDX) Delisted Chief Medical Officer 21,687 — — -$713.2K 10 2018-02-22

Recent Filings

53 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-09-04 VCYT Notice (144) −13,110 -$585.6K EDGAR
2026-09-04 VCYT Mixed −16,749 -$727.7K EDGAR
2026-06-04 VCYT Tax (F) −3,730 -$178.3K EDGAR
2026-03-10 VCYT Grant (A) +36,181 $0 EDGAR
2026-03-04 VCYT Mixed −19,460 -$702.7K EDGAR
2026-03-02 VCYT Notice (144) −13,425 -$491.2K EDGAR
2026-03-02 VCYT Mixed +47,320 -$948.8K EDGAR
2025-12-04 VCYT Tax (F) −2,955 -$136.4K EDGAR
2025-10-07 VCYT Sell (S) −8,349 -$300.7K EDGAR
2025-10-06 VCYT Notice (144) −8,349 -$300.6K EDGAR
Showing 1–10 of 53
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.